Press Releases

WATERBURY, Conn., Feb. 27, 2020 /PRNewswire/ -- Therap's Health Tracking modules have undergone enhancements to their interface, both for system cohesion and ease of use by health professionals and care providers supporting individuals with intellectual and developmental disabilities.  The new module design maintains functionality, including reporting, data en

WATERBURY, Conn., Feb. 27, 2020 /PRNewswire/ -- Therap's electronic health record and documentation software offers multiple features designed to improve communication and documentation, including observations, issues, and daily notes during service delivery times and transfers.  Notes within Therap are configurable to notify team members by classification and

PALO ALTO, Calif., Feb. 27, 2020 /PRNewswire/ -- Varian (NYSE: VAR) today announced that J. Michael Bruff, chief financial officer and Anshul Maheshwari, vice president, investor relations and treasurer will be participating in the following investor conferences:Barclays Global He

SEATTLE, Feb. 27, 2020 /PRNewswire/ -- Lux Pot Shop, leaders in Seattle's Cannabis industry, will officially open the doors to their third location in Fremont on Sunday, March 8, 2020.

SAN FRANCISCO, Feb. 27, 2020 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter and full year ended December 31, 2019.Cash and investments in marketable securities at December 31, 2019 were approximately $1.6 billion as

SAN DIEGO, Feb. 27, 2020 /PRNewswire/ -- Trovagene, Inc. (Nasdaq: TROV), a clinical-stage, Precision Cancer Medicine™ oncology therapeutics company developing drugs that target cell division (mitosis) for the treatment of various cancers including prostate, colorectal and leukemia, today announced company highlights and financial results for the f

NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved NURTEC™ ODT (rimegepant) for the acute treatment of migraine in adults. NURTEC ODT is the first FDA-approved product for Biohaven, a company dedicated to advancing innovative therapi

NEW YORK, Feb. 27, 2020 /PRNewswire/ -- Stellar Health, a leading organization in value-based care, announced today, that the Stellar Health Web Application and supporting infrastructure has earned

SAN DIEGO, Feb. 27, 2020 /PRNewswire/ -- Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results and business highlights for the fourth

VALENCIA, Calif., Feb. 27, 2020 /PRNewswire/ -- Valencia Technologies Corporation ("Valencia"), a private medical device company, today announced interim efficacy data from the eCoin Pivotal Clinical Trial will be presented at the upcoming Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) 2020 Ann